Gabapentin Capsule
Product Images NDC 72162-1534

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This is a description of a study evaluating the effect of different doses of Gabapentin on pain scores over a 7-week period. The study design involved a fixed dose period of 4 weeks followed by a dose titration period of 3 weeks. The baseline pain score was measured, and participants were given either a placebo or Gabapentin at a dose of 1800 mg/day or 2400 mg/day. Pain scores were recorded at various time points throughout the 7-week period.*
FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Label (Lbl721621534)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.